Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology […] The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology […] The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.

Biotech Pioneer Expands Into Web3 With Altcoin Investment

2025/10/07 22:07
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology and blockchain innovation. The company believes decentralized science (DeSci) could transform how breakthroughs are funded, shared, and rewarded, offering scientists a transparent alternative to traditional publishing models.

ResearchHub, founded by Coinbase CEO Brian Armstrong in 2019, allows researchers to share findings, peer-review work, and earn RSC tokens for their contributions. The project has drawn attention for its attempt to “open-source” the scientific process – removing paywalls and bureaucracy that often slow discovery.

Silo Pharma’s CEO, Eric Weisblum, said the investment represents more than a financial move: it’s a philosophical alignment with the next evolution of research infrastructure. “We see blockchain not only as a financial tool but as a mechanism for accelerating innovation in medicine and beyond,” he explained.

READ MORE:

Bitcoin’s Massive Rally Leaves Altcoins Behind, Says 10x Research

Following Silo’s announcement, ResearchCoin’s price climbed by around 4%, bringing its market capitalization to roughly $60 million. The token is currently listed on Coinbase, where trading volume surged as news of Silo’s involvement spread.

By stepping into the DeSci space, Silo Pharma becomes one of the first biopharma firms to directly support a Web3-driven research model. It signals a growing trend of traditional science companies embracing blockchain to democratize access to knowledge and potentially fast-track global collaboration in biomedical discovery.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!